Japan
· Delayed Price · Currency is JPY COSMOS Pharmaceutical Statistics
Total Valuation
TYO:3349 has a market cap or net worth of JPY 739.71 billion. The enterprise value is 745.47 billion.
| Market Cap | 739.71B |
| Enterprise Value | 745.47B |
Important Dates
The next estimated earnings date is Friday, July 11, 2025.
| Earnings Date | Jul 11, 2025 |
| Ex-Dividend Date | May 29, 2025 |
Share Statistics
TYO:3349 has 79.26 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 79.26M |
| Shares Outstanding | 79.26M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 38.76% |
| Owned by Institutions (%) | 27.22% |
| Float | 44.18M |
Valuation Ratios
The trailing PE ratio is 25.13 and the forward PE ratio is 23.39. TYO:3349's PEG ratio is 2.41.
| PE Ratio | 25.13 |
| Forward PE | 23.39 |
| PS Ratio | 0.74 |
| PB Ratio | 2.97 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.41 |
Enterprise Valuation
| EV / Earnings | 25.32 |
| EV / Sales | 0.74 |
| EV / EBITDA | n/a |
| EV / EBIT | 19.15 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 0.11.
| Current Ratio | 0.65 |
| Quick Ratio | 0.12 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 203.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 13.98% |
| Revenue Per Employee | 181.78M |
| Profits Per Employee | 5.34M |
| Employee Count | 5,512 |
| Asset Turnover | 2.22 |
| Inventory Turnover | 9.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.91% in the last 52 weeks. The beta is 0.29, so TYO:3349's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +27.91% |
| 50-Day Moving Average | 8,031.92 |
| 200-Day Moving Average | 7,327.07 |
| Relative Strength Index (RSI) | 60.21 |
| Average Volume (20 Days) | 472,310 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:3349 had revenue of JPY 1.00 trillion and earned 29.44 billion in profits. Earnings per share was 371.45.
| Revenue | 1.00T |
| Gross Profit | 207.85B |
| Operating Income | 38.94B |
| Pretax Income | 40.96B |
| Net Income | 29.44B |
| EBITDA | n/a |
| EBIT | 38.94B |
| Earnings Per Share (EPS) | 371.45 |
Balance Sheet
The company has 22.77 billion in cash and 28.53 billion in debt, giving a net cash position of -5.76 billion or -72.73 per share.
| Cash & Cash Equivalents | 22.77B |
| Total Debt | 28.53B |
| Net Cash | -5.76B |
| Net Cash Per Share | -72.73 |
| Equity (Book Value) | 248.82B |
| Book Value Per Share | 3,139.42 |
| Working Capital | -68.80B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 20.74%, with operating and profit margins of 3.89% and 2.94%.
| Gross Margin | 20.74% |
| Operating Margin | 3.89% |
| Pretax Margin | 4.09% |
| Profit Margin | 2.94% |
| EBITDA Margin | n/a |
| EBIT Margin | 3.89% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 65.00, which amounts to a dividend yield of 0.73%.
| Dividend Per Share | 65.00 |
| Dividend Yield | 0.73% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.69% |
| Earnings Yield | 3.98% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 29, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Aug 29, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
TYO:3349 has an Altman Z-Score of 4.39.
| Altman Z-Score | 4.39 |
| Piotroski F-Score | n/a |